COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing

BMC Medical Genomics

Research

Lixian Zhang¹  Dongqiang Zhao²  Meiru Chen³  Xinying Zhu⁴ 

[1] Department of Gastroenterology, Hengshui People’s Hospital, 053000, Hengshui, Hebei Province, China;Department of Gastroenterology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei Province, China;Department of Gastroenterology, The Second Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei Province, China;Department of Gastroenterology, Hengshui People’s Hospital, 053000, Hengshui, Hebei Province, China;Department of Gastroenterology, The Third Hospital of Hebei Medical University, 050000, Shijiazhuang, Hebei Province, China;

关键词: COL5A2;    Gastric cancer (GC);    Prognosis;    Immune cell infiltration;    Immunotherapy;   

DOI  :  10.1186/s12920-023-01659-9

 received in 2023-01-23, accepted in 2023-09-09,  发布年份 2023

来源: Springer

【 摘 要 】

BackgroundThere is still a therapeutic challenge in treating gastric cancer (GC) due to its high incidence and poor prognosis. Collagen type V alpha 2 (COL5A2) is increased in various cancers, yet it remains unclear how it contributes to the prognosis and immunity of GC.MethodsThe Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets were used to download transcriptome profiling (TCGA-STAD; GSE84437), single-cell RNA sequencing (scRNA-seq) data (GSE167297) and clinical information. COL5A2 expression and its relationship with clinicopathological factors were analyzed. We conducted survival analysis and Cox regression analysis to evaluate the prognosis and independent factors of GC. Co-expressed analysis was also performed. To identify the underlying mechanism, we conducted analyses of differentially expressed genes (DEGs) and functional enrichment. The correlations between COL5A2 expression and immune cell infiltration levels and immune infiltrate gene marker sets were further explored. Additionally, we analyzed the association of COL5A2 expression with immunological checkpoint molecules. Furthermore, the relationship between COL5A2 expression and immunotherapy sensitivity was also investigated.ResultsCOL5A2 expression was elevated in GC. More than this, the scRNA-seq analysis revealed that COL5A2 expression had a spatial gradient. The upregulated COL5A2 was associated with worse overall survival. A significant correlation was found between COL5A2 overexpression and age, T classification and clinical stage in GC. COL5A2 was found to be an independent factor for the unfortunate outcome in Cox regression analysis. The co-expressed genes of COL5A2 were associated with tumor stage or poor survival. Enrichment analysis revealed that the DEGs were mainly associated with extracellular matrix (ECM)-related processes, PI3K-AKT signaling pathway, and focal adhesion. GSEA analyses revealed that COL5A2 was associated with tumor progression-related pathways. Meanwhile, COL5A2 expression was correlated with tumor-infiltrating immune cells. Moreover, immunophenoscore (IPS) analysis and PRJEB25780 cohorts showed that patients with low COL5A2 expression were highly sensitive to immunotherapy.ConclusionsCOL5A2 might act as a prognostic biomarker of GC prognosis and immune infiltration and may provide a therapeutic intervention strategy.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

12951_2023_2095_Article_IEq1.gif

Fig. 6

13690_2023_1170_Article_IEq161.gif

Fig. 1

13690_2023_1170_Article_IEq48.gif

13690_2023_1170_Article_IEq156.gif

Fig. 1

Fig. 5

13690_2023_1170_Article_IEq30.gif

Fig. 5

Fig. 2

Fig. 3

Fig. 4